171 related articles for article (PubMed ID: 29239119)
21. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
[TBL] [Abstract][Full Text] [Related]
22. An aggressive CD4
Frankhouse KA; Rout ED; Hughes KL; Labadie JD; Yoshimoto JA; Lana SE; Avery PR; Avery AC
Vet Comp Oncol; 2022 Jun; 20(2):416-426. PubMed ID: 34792269
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in canine acute leukaemias: a retrospective study.
Novacco M; Comazzi S; Marconato L; Cozzi M; Stefanello D; Aresu L; Martini V
Vet Comp Oncol; 2016 Dec; 14(4):409-416. PubMed ID: 25623886
[TBL] [Abstract][Full Text] [Related]
24. Atypical chronic myeloid leukemia in a German Shepherd Dog.
Marino CL; Tran JNSN; Stokol T
J Vet Diagn Invest; 2017 May; 29(3):338-345. PubMed ID: 28205462
[TBL] [Abstract][Full Text] [Related]
25. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloblastic leukaemia in a dog.
Keller P; Sager P; Freudiger U; Speck B
J Comp Pathol; 1985 Oct; 95(4):619-32. PubMed ID: 3864796
[TBL] [Abstract][Full Text] [Related]
27. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.
Buldini B; Rizzati F; Masetti R; Fagioli F; Menna G; Micalizzi C; Putti MC; Rizzari C; Santoro N; Zecca M; Disarò S; Rondelli R; Merli P; Pigazzi M; Pession A; Locatelli F; Basso G
Br J Haematol; 2017 Apr; 177(1):116-126. PubMed ID: 28240765
[TBL] [Abstract][Full Text] [Related]
30. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X; Cherian S
Clin Lab Med; 2017 Dec; 37(4):753-769. PubMed ID: 29128067
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Acute Leukaemias by Flow Cytometry and Its Correlation With Diagnosis Using Morphological and Special Staining Techniques.
Ahmad N; Kumari N; Tirkey D; Mahto SK; Jawaid M
Cureus; 2024 Feb; 16(2):e54126. PubMed ID: 38487155
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modelling human myeloid leukaemia.
Bronzini I; Aresu L; Paganin M; Marchioretto L; Comazzi S; Cian F; Riondato F; Marconato L; Martini V; Te Kronnie G
Vet Comp Oncol; 2017 Sep; 15(3):910-918. PubMed ID: 27098563
[TBL] [Abstract][Full Text] [Related]
33. Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category.
Weinberg OK; Hasserjian RP; Li B; Pozdnyakova O
J Clin Pathol; 2017 Feb; 70(2):109-115. PubMed ID: 27387988
[TBL] [Abstract][Full Text] [Related]
34. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
Al-Mawali A; Pinto AD; Al-Zadjali S
Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
[TBL] [Abstract][Full Text] [Related]
35. Acute leukemia in six horses (1990-2012).
Barrell EA; Asakawa MG; Felippe MJB; Divers TJ; Stokol T
J Vet Diagn Invest; 2017 Jul; 29(4):529-535. PubMed ID: 28467276
[TBL] [Abstract][Full Text] [Related]
36. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
[TBL] [Abstract][Full Text] [Related]
37. Assessment of bone marrow infiltration diagnosed by flow cytometry in canine large B cell lymphoma: prognostic significance and proposal of a cut-off value.
Marconato L; Martini V; Aresu L; Sampaolo M; Valentini F; Rinaldi V; Comazzi S
Vet J; 2013 Sep; 197(3):776-81. PubMed ID: 23735731
[TBL] [Abstract][Full Text] [Related]
38. Cytochemical Staining.
Paessler ME; Helfrich M; Wertheim GBW
Methods Mol Biol; 2017; 1633():19-32. PubMed ID: 28735478
[TBL] [Abstract][Full Text] [Related]
39. NSE/αNAE positivity in B-lineage acute lymphoblastic leukemia: revisiting a potential cytochemical diagnostic pitfall.
Sharma P; Tyagi S
Biotech Histochem; 2014 Jan; 89(1):19-22. PubMed ID: 23957699
[TBL] [Abstract][Full Text] [Related]
40. [Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study].
Creutzig U; Ritter J; Ludwig WD; Harbott J; Löffler H; Schellong G
Klin Padiatr; 1993; 205(4):272-80. PubMed ID: 8377447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
